MUC1 and pulmonary fibrosis: As compared to conventional biomarkers of IPF, such as Krebs von den Lungen-6 (KL-6) and matrix metalloproteases, EVs and miRNAs seem to be quite specific to cell conditions in pulmonary fibrosis [9].